A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Name: A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine
Published: 2010
License: Public Domain

AbbVie (prior sponsor, Abbott) · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

lipodystrophy

hiv infection, lipodystrophy, lipoatrophy, antiretroviral treatment, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Related documents